Abbott Reports Strong Revenue and Sales Growth in Third Quarter Abbott has announced financial outcomes for the 3rd quarter ended Sept. 30, 2008. Diluted income per talk about, excluding specified items, were $0.79, above Abbott’s previously announced guidance selection of $0.76 – $0.78, reflecting 17.9 % growth. Diluted earnings per talk about under Generally Recognized Accounting Principles were $0.69, up 50.0 %. Today, Abbott is usually raising its assistance for full-calendar year 2008 adjusted revenue per share to $3.31 – $3.33 from $3.24 – $3.28, excluding specified items. Projected revenue per talk about under GAAP is $3.23 – $3.25.Doctors at Brigham and Women's Medical center in Boston performed the nation's first full-face transplantation in 2011 and also have subsequently completed 4 additional face transplants. The procedure is conducted on patients who’ve lost some or all of their face due to damage or disease. In the scholarly study, a extensive research team led by Frank J. Rybicki, M.D., radiologist and director of the hospital's Applied Imaging Technology Laboratory, Bohdan Pomahac, M.D., lead face transplantation doctor, and Amir Imanzadeh, M.D., research fellow, assessed the medical impact of using 3-D printed types of the recipient's mind in the look of face transplantation surgery. This is a complex surgery and its success is dependent on medical planning, Dr. Rybicki stated.